• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Financial Toxicity and Cost-Related Non-Adherence in Patients with Chronic Blood Cancers.

    Taylor, Lauren Alexis
    : https://etd.library.vanderbilt.edu/etd-03202019-094735
    http://hdl.handle.net/1803/10969
    : 2019-03-20

    Abstract

    A growing body of evidence has coined a new term in oncology research and practice – “Financial Toxicity” – in relation to the high out-of-pocket costs and cost-sharing insinuated on cancer patients. More research is needed to elucidate what factors are associated with financial toxicity, the relationship between oral anticancer drugs and financial burden, and how quality of life is related to financial burden. A cross-sectional, one-time survey for patients with Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) through “Patient Power”, an online community of blood cancer patients, was administered to address predictive factors of financial burden among this patient population and the associations between financial toxicity health-related quality of life. Patients with CLL or MM report a significant level of cancer-related financial burdens. Patients who take anticancer drugs as part of treatment experience significantly more financial burdens as those who do not take anticancer drugs. This suggests that the expensive price tag of recently innovated oral anticancer drugs is associated with financial toxicity. Lastly, patients who report higher financial burden had significantly lower mental and physical health quality of life scores. Thus, policymakers, drug manufacturers, and physicians must address the growing body of evidence that cancer patients cannot afford life-saving treatments. Additional interventions to alleviate cancer-related financial burdens are needed.
    Show full item record

    Files in this item

    Icon
    Name:
    Thesis.pdf
    Size:
    1007.Kb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy